Page last updated: 2024-10-18
glycine and Complex Regional Pain Syndromes
glycine has been researched along with Complex Regional Pain Syndromes in 1 studies
Complex Regional Pain Syndromes: Conditions characterized by pain involving an extremity or other body region, HYPERESTHESIA, and localized autonomic dysfunction following injury to soft tissue or nerve. The pain is usually associated with ERYTHEMA; SKIN TEMPERATURE changes, abnormal sudomotor activity (i.e., changes in sweating due to altered sympathetic innervation) or edema. The degree of pain and other manifestations is out of proportion to that expected from the inciting event. Two subtypes of this condition have been described: type I; (REFLEX SYMPATHETIC DYSTROPHY) and type II; (CAUSALGIA). (From Pain 1995 Oct;63(1):127-33)
Research Excerpts
| Excerpt | Relevance | Reference |
|---|
| "Since glycinergic neurotransmission plays an important inhibitory role in the processing of sensory and motor information, intrathecal glycine (ITG) administration may be a potential therapy for both pain and movement disorders in patients with complex regional pain syndrome (CRPS)." | 9.14 | Intrathecal glycine for pain and dystonia in complex regional pain syndrome. ( Marinus, J; Munts, AG; Onkenhout, W; Teepe-Twiss, IM; van der Plas, AA; van Gerven, JM; van Hilten, JJ; Voormolen, JH, 2009) |
| "Since glycinergic neurotransmission plays an important inhibitory role in the processing of sensory and motor information, intrathecal glycine (ITG) administration may be a potential therapy for both pain and movement disorders in patients with complex regional pain syndrome (CRPS)." | 5.14 | Intrathecal glycine for pain and dystonia in complex regional pain syndrome. ( Marinus, J; Munts, AG; Onkenhout, W; Teepe-Twiss, IM; van der Plas, AA; van Gerven, JM; van Hilten, JJ; Voormolen, JH, 2009) |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|
| Munts, AG | 1 |
| van der Plas, AA | 1 |
| Voormolen, JH | 1 |
| Marinus, J | 1 |
| Teepe-Twiss, IM | 1 |
| Onkenhout, W | 1 |
| van Gerven, JM | 1 |
| van Hilten, JJ | 1 |
Clinical Trials (1)
Trial Overview
| Trial | Phase | Enrollment | Study Type | Start Date | Status |
|---|
| Intrathecal Immunoglobulin for Treatment of Adult Patients With Tetanus: a Randomized Controlled 2x2 Factorial Trial[NCT02999815] | Phase 1/Phase 2 | 272 participants (Actual) | Interventional | 2017-02-13 | Completed |
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Trials
1 trial available for glycine and Complex Regional Pain Syndromes